Bryant R England
Overview
Explore the profile of Bryant R England including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wheeler A, Baker J, Riley 4th T, Johnson T, Yang Y, Roul P, et al.
Arthritis Rheumatol
. 2025 Mar;
PMID: 40033001
Objective: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant cause of morbidity and mortality among patients with RA, yet effective risk stratification for RA-ILD is lacking. We sought to...
2.
Kronzer V, Yang Y, Roul P, Crooks J, Crowson C, Davis 3rd J, et al.
Arthritis Rheumatol
. 2025 Feb;
PMID: 39989247
No abstract available.
3.
McDermott G, Gill R, Byrne S, Gagne S, Wang X, Paudel M, et al.
medRxiv
. 2025 Feb;
PMID: 39974108
Background: Risk factors and screening strategies for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) have received limited evaluation in patients with early RA. We investigated RA-ILD prevalence, risk factors, and the...
4.
Tokareva K, Peterson A, Baraff A, Chung S, Barton J, Baker J, et al.
BMC Rheumatol
. 2025 Jan;
9(1):7.
PMID: 39819734
Background: Biologic (b) and targeted synthetic (ts) disease-modifying anti-rheumatic drugs (DMARDs) used in the management of rheumatoid arthritis (RA) target inflammatory pathways implicated in the pathogenesis of multiple myeloma (MM)....
5.
Kronzer V, Yang Y, Roul P, Crooks J, Crowson C, Davis 3rd J, et al.
Arthritis Rheumatol
. 2025 Jan;
PMID: 39800945
Objective: The aim of this study was to determine whether pollutants such as fire smoke-related particulate matter <2.5 μm (PM) are associated with incident rheumatoid arthritis (RA) and RA-associated interstitial...
6.
England B, Baker J, George M, Johnson T, Yang Y, Roul P, et al.
Lancet Rheumatol
. 2025 Jan;
7(3):e166-e177.
PMID: 39793598
Background: Uncertainty exists regarding patient outcomes when using TNF inhibitors versus other biological and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis-associated interstitial lung disease (ILD). We compared survival...
7.
Smith I, England B, Pagidipati N, Bosworth H
Expert Rev Pharmacoecon Outcomes Res
. 2025 Jan;
1-13.
PMID: 39772854
Introduction: Rheumatoid arthritis (RA) is a systemic inflammatory disease associated with an increased risk of cardiovascular disease (CVD) and premature mortality. The risk of CVD is closely associated with RA...
8.
Ngo L, Rekowski M, Koestler D, Yorozuya T, Saito A, Azeem I, et al.
ERJ Open Res
. 2024 Dec;
10(6.
PMID: 39687393
Background: Idiopathic interstitial pneumonias (IIPs), such as idiopathic pulmonary fibrosis and interstitial pneumonia with autoimmune features, present diagnostic and therapeutic challenges due to their heterogeneous nature. This study aimed to...
9.
Mikuls T, Baker J, Cannon G, England B, Kerr G, Reimold A
Semin Arthritis Rheum
. 2024 Nov;
70S():152580.
PMID: 39580339
Background: As the largest integrated healthcare system in the U.S., the Veterans Affairs (VA) provides a unique context for the conduct of clinical and clinical-translational research in rheumatoid arthritis (RA)....
10.
Aripova N, Duryee M, Zhou W, England B, Hunter C, Klingemann L, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Nov;
328(1):L134-L147.
PMID: 39560968
The objective of this study was to assess fibrinogen (FIB) comodified with citrulline (CIT) and/or malondialdehyde-acetaldehyde (MAA) initiates macrophage-fibroblast interactions, leading to extracellular matrix (ECM) deposition that characterizes rheumatoid arthritis-associated...